INS and metabolic dysfunction-associated steatotic liver disease: Raised insulin levels and enhanced lipogenesis with hepatic triglyceride formation have previously been associated with the development of non-alcoholic fatty liver disease, where hepatocytes become insulin resistant and fail to repress lipogenesis and triglyceride accumulation in response to high insulin levels [23, 24].